Blizzard & Nabers

Texas-Based, National Results

National Pharmaceutical Law Firm Investigates Legal Action Against Biogen Idec and Elan, Makers of Tysabri

Blog header
National Pharmaceutical Law Firm Investigates Legal Action Against Biogen Idec and Elan, Makers of Tysabri
06.01.2014 News

Blizzard & Nabers, LLC, one of the nation's leading pharmaceutical litigation firms, is investigating legal action against Biogen Idec and Elan, the makers of the dangerous drug Tysabri (natalizumab), a medication used to treat multiple sclerosis patients..."When you consider that Tysabri causes PML which results in either death or severe brain damage, and that the risk of contracting PML increases each month that a patient takes the drug, it is difficult to understand why the FDA allows it to remain on the market," said Ed Blizzard, “We will continue to investigate and may seek justice on behalf of these suffering patients.”
Read More »
 

-->